Rifabutin
Term · Oncology and biomedicine · MLC-T-ONC-007451
A drug used to prevent the spread of a bacterium called in patients with advanced HIV (the virus that causes AIDS) infection. It blocks an enzyme that the bacteria need to grow. It is a type of antibiotic. Also called Mycobutin.
A semisynthetic ansamycin antibiotic with potent antimycobacterial properties. Rifabutin inhibits bacterial DNA-dependent RNA polymerase, thereby suppressing the initiation of RNA formation and leading to inhibition of RNA synthesis and transcription.
| Identifier | MLC-T-ONC-007451 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Mycobutin |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-007451",
"term": "Rifabutin",
"field": "Oncology and biomedicine",
"definitions": [
"A drug used to prevent the spread of a bacterium called in patients with advanced HIV (the virus that causes AIDS) infection. It blocks an enzyme that the bacteria need to grow. It is a type of antibiotic. Also called Mycobutin.",
"A semisynthetic ansamycin antibiotic with potent antimycobacterial properties. Rifabutin inhibits bacterial DNA-dependent RNA polymerase, thereby suppressing the initiation of RNA formation and leading to inhibition of RNA synthesis and transcription."
],
"synonyms": [
"Mycobutin"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/rifabutin/"
}
Record 14,476 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.